Identification of CNGB1 as a Predictor of Response to Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer

European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines

(2020) J. Alfred Witjes et al.   EUROPEAN UROLOGY

Immunohistochemistry-Based Taxonomical Classification of Bladder Cancer Predicts Response to Neoadjuvant Chemotherapy

(2020) Albert Font et al.   Cancers

Molecular correlates of cisplatin-based chemotherapy response in muscle invasive bladder cancer by integrated multi-omics analysis

(2020) Ann Taber et al.   Nature Communications

Diltiazem potentiates the cytotoxicity of gemcitabine and 5-fluorouracil in PANC-1 human pancreatic cancer cells through inhibition of P-glycoprotein

(2020) Hesham A. El-Mahdy et al.   LIFE SCIENCES

Dysregulation of EMT Drives the Progression to Clinically Aggressive Sarcomatoid Bladder Cancer

(2019) Charles C. Guo et al.   Cell Reports

Increased expression of Psoriasin is correlated with poor prognosis of bladder transitional cell carcinoma by promoting invasion and proliferation

(2019) Jia Liu et al.   ONCOLOGY REPORTS

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

(2018) Freddie Bray et al.   CA-A CANCER JOURNAL FOR CLINICIANS

A machine learning approach for the identification of new biomarkers for knee osteoarthritis development in overweight and obese women

(2017) N. Lazzarini et al.   OSTEOARTHRITIS AND CARTILAGE

Origins of Bladder Cancer

(2016) Bogdan Czerniak et al.   Annual Review of Pathology-Mechanisms of Disease

ERBB2 Mutations Characterize a Subgroup of Muscle-invasive Bladder Cancers with Excellent Response to Neoadjuvant Chemotherapy

(2016) Floris H. Groenendijk et al.   EUROPEAN UROLOGY

A Prognostic Gene Expression Signature in the Molecular Classification of Chemotherapy-naïve Urothelial Cancer is Predictive of Clinical Outcomes from Neoadjuvant Chemotherapy: A Phase 2 Trial of Dose-dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin with Bevacizumab in Urothelial Cancer

(2016) David J. McConkey et al.   EUROPEAN UROLOGY

Clinical Validation of Chemotherapy Response BiomarkerERCC2in Muscle-Invasive Urothelial Bladder Carcinoma

(2016) David Liu et al.   JAMA Oncology

A machine learning heuristic to identify biologically relevant and minimal biomarker panels from omics data

(2015) Anna L Swan et al.   BMC GENOMICS

MDR1 and ERCC1 Expression Predict Outcome of Patients with Locally Advanced Bladder Cancer Receiving Adjuvant Chemotherapy

(2015) Andreas-Claudius Hoffmann et al.   NEOPLASIA

S100A9 and EGFR gene signatures predict disease progression in muscle invasive bladder cancer patients after chemotherapy

(2014) W. T. Kim et al.   ANNALS OF ONCOLOGY

Identification of Distinct Basal and Luminal Subtypes of Muscle-Invasive Bladder Cancer with Different Sensitivities to Frontline Chemotherapy

(2014) Woonyoung Choi et al.   CANCER CELL

Neoadjuvant Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin With Pegfilgrastim Support in Muscle-Invasive Urothelial Cancer: Pathologic, Radiologic, and Biomarker Correlates

(2014) Toni K. Choueiri et al.   JOURNAL OF CLINICAL ONCOLOGY

Somatic ERCC2 Mutations Correlate with Cisplatin Sensitivity in Muscle-Invasive Urothelial Carcinoma

(2014) E. M. Van Allen et al.   Cancer Discovery

A Prognostic DNA Methylation Signature for Stage I Non–Small-Cell Lung Cancer

(2013) Juan Sandoval et al.   JOURNAL OF CLINICAL ONCOLOGY

Side Population in Human Non-Muscle Invasive Bladder Cancer Enriches for Cancer Stem Cells That Are Maintained by MAPK Signalling

(2012) Anastasia C. Hepburn et al.   PLoS One

Study on the Impact of Partition-Induced Dataset Shift on $k$-Fold Cross-Validation

(2012) J. G. Moreno-Torres et al.   IEEE Transactions on Neural Networks and Learning Systems

International Phase III Trial Assessing Neoadjuvant Cisplatin, Methotrexate, and Vinblastine Chemotherapy for Muscle-Invasive Bladder Cancer: Long-Term Results of the BA06 30894 Trial

(2011)   JOURNAL OF CLINICAL ONCOLOGY

BRCA1 mRNA expression and outcome to neoadjuvant cisplatin-based chemotherapy in bladder cancer

(2010) A. Font et al.   ANNALS OF ONCOLOGY

Enhanced S100 calcium-binding protein P expression sensitizes human bladder cancer cells to cisplatin

(2010) Masaki Shiota et al.   BJU INTERNATIONAL

Predictive value of progression-related gene classifier in primary non-muscle invasive bladder cancer

(2010) Wun-Jae Kim et al.   Molecular Cancer

Predicting response of bladder cancers to gemcitabine and carboplatin neoadjuvant chemotherapy through genome-wide gene expression profiling

(2010) YOICHIRO KATO et al.   Experimental and Therapeutic Medicine

Concordant Gene Expression Signatures Predict Clinical Outcomes of Cancer Patients Undergoing Systemic Therapy

(2009) P. D. Williams et al.   CANCER RESEARCH

The prince and the pauper. A tale of anticancer targeted agents

(2008) Alfonso Dueñas-González et al.   Molecular Cancer